Obesity as a risk factor for sustained ventricular tachyarrhythmias in MADIT II patients

Journal of Cardiovascular Electrophysiology

Volumn 18, Issue 2, 2007, Pages 181-184

  Pietrasik, Grzegorz ^a   Goldenberg, Ilan ^a   McNitt, Scott ^a   Moss, Arthur J ^a   Zareba, Wojciech ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Heart failure; Implantable cardioverter defibrillator; Obesity; Ventricular tachycardia

Indexed keywords

ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; DEFIBRILLATOR; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEART DEATH; HEART INFARCTION; HEART LEFT VENTRICLE FAILURE; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OBESITY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SUDDEN DEATH;

ADULT; AGED; AGED, 80 AND OVER; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; OBESITY; PREVALENCE; RISK ASSESSMENT; RISK FACTORS; SURVIVAL ANALYSIS; SURVIVAL RATE; TACHYCARDIA, VENTRICULAR; VENTRICULAR DYSFUNCTION, LEFT;

EID: 33846368454     PISSN: 10453873     EISSN: 15408167     Source Type: Journal    
DOI: 10.1111/j.1540-8167.2006.00680.x     Document Type: Article

References (21)

1. Cleland JG, Erhardt L, Murray G, Hall AS, Ball SG: Effect of ramipril on morbidity and mode of death among survivors of acute myocardial infarction with clinical evidence of heart failure. A report form the AIRE Study Investigators. Eur Heart J 1997;18:41-51.
2. Narang R, Cleland JG, Erhardt L, Ball SG, Coats AJ, Cowley AJ, Dargie HJ, Hall AS, Hampton JR, Poole-Wilson PA: Mode of death in chronic heart failure. A request and proposition for more accurate classification. Eur Heart J 1996;17:1390-1403.
3. Vos MA, Crijns HJ: Ventricular tachycardia in patients with hypertrophy and heart failure. In: Zipes DP, Jalife J, eds. Cardiac Electrophysiology: From Cell to Bedside. Fourth edition. Philadelphia: Saunders, 2004, pp. 610-613.
4. Zacharias A, Schwann T, Riordan C, Durham S, Shah A, Habib R: Obesity and risk of new-onset atrial fibrillation after cardiac surgery. Circulation 2005;112:3247-3255.
5. Wang T, Parise H, Levy D, D'Agostino RB Sr, Wolf PA, Vasan RS, Benjamin EJ: Obesity and the risk of new-onset atrial fibrillation. JAMA 292:2471-2477.
6. Bharatti S, Lev M: Cardiac conduction system involvement in sudden death of obese young people. Am Heart J 1995;129:273-281.
7. Mshui ME, Saikawa T, Ito K, Hara M, Sakata T: QT interval and QT dispersion before and after diet therapy in patients with simple obesity. Proc Soc Exp Biol Med 1999 220:133-138.
8. Fraley MA, Birchem JA, Senkottaiyan N, Alpert MA: Obesity and the electrocardiogram. Obes Rev 2005;6:275-281.
9. Chan JM, Rimm EB, Colditz GA, Stampfer MJ, Willett WC: Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men. Diabetes Care 1994;17:961-969.
10. Ewing DJ, Campbell IW, Clarke BF: The natural history of diabetic autonomic neuropathy. Q J Med 1980;49:95-108.
11. Stevens MJ, Raffel DM, Allman KC, Dayanikli F, Ficaro E, Sandford T, Wieland DM, Pfeifer MA, Schwaiger M: Cardiac sympathetic dysinnervation in diabetes: Implications for enhanced cardiovascular risk. Circulation 1998;98:961-968.
12. Sivieri R, Vegilo M, Chinaglia A, Scaglione P, Cavallo-Perin P: Prevalence of QT prolongation in a type 1 diabetic population and its association with autonomic neuropathy. The Neuropathy Study Group of Italian Society for the Study of Diabetes. Diabet Med 1993;10:920-924.
13. Veglio M, Borra M, Stevens LK, Fuller JH, Perin PC: The relation between QTc interval prolongation and diabetic complications. The EU-RODIAB IDDM Complication Study Group. Diabetologia 1999;42:68-75.
14. Suarez GA, Clark VM, Norell JE, Kottke TE, Callahan MJ, O'Brien PC, Low PA, Dyck PJ: Sudden cardiac death in diabetes mellitus: Risk factors in the Rochester diabetic neuropathy study. J Neurosurg Psychiatry 2005;76:240-245.
15. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgins SL, Brown MW, Andrews ML; MADIT II Investigators: Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-883.
16. National Institutes of Health, National Heart, Lung, and Blood Institute: Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: The evidence report. Obes Res 1998;6(Suppl 2):S51-S210.
17. Greenberg H, Case RB, Moss AJ, Brown MW, Carroll ER, Andrews ML; MADIT-II Investigators: Analysis of mortality events in the Multimember Automatic Defibrillator Implantation Trial (MADIT-II). J Am Coll Cardiol 2004;43:1459-1465.
18. Daubert JP, Zareba W, Hall WJ, Schuger C, Corsello A, Leon AR, Andrews ML, McNitt S, Huang DT, Moss AJ: Predictive value of ventricular arrhythmia inducibility for subsequent ventricular tachycardia or ventricular fibrillation in Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients. J Am Coll Cardiol 2006:47:98-107.
19. Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, Zhang Y, Fei H, Kim S, Lallone R, Ranganathan S: Leptin levels in human and rodent: Measurement of plasma leptin and obRNA in obese and weight reduced subjects. Nat Med 1995;1:1155-1161.
20. Carlyle M, Jones OB, Kuo JJ, Hall JE: Chronic cardiovascular and renal actions of leptin: Role of adrenergic activity. Hypertension 2002;39:496-501.
21. Winnicki M, Phillips BG, Accurso V, Van de Borne P, Shamsuzzaman A, Patil K, Narkiewicz K, Somers VK: Independent association between plasma leptin levels and heart rate in heart transplant recipients. Circulation 2001;104:384-386.